Lung cancer: current therapies and new targeted treatments
Lung cancer is the most frequent cause of cancer-related deaths worldwide. Every year, 1· 8
million people are diagnosed with lung cancer, and 1· 6 million people die as a result of the …
million people are diagnosed with lung cancer, and 1· 6 million people die as a result of the …
The global burden of lung cancer: current status and future trends
A Leiter, RR Veluswamy, JP Wisnivesky - Nature Reviews Clinical …, 2023 - nature.com
Lung cancer is the leading cause of cancer-related death worldwide. However, lung cancer
incidence and mortality rates differ substantially across the world, reflecting varying patterns …
incidence and mortality rates differ substantially across the world, reflecting varying patterns …
Lung cancer screening
SJ Adams, E Stone, DR Baldwin, R Vliegenthart, P Lee… - The Lancet, 2023 - thelancet.com
Randomised controlled trials, including the National Lung Screening Trial (NLST) and the
NELSON trial, have shown reduced mortality with lung cancer screening with low-dose CT …
NELSON trial, have shown reduced mortality with lung cancer screening with low-dose CT …
Non-small-cell lung cancer in 2022: A review for general practitioners in oncology
H Mithoowani, M Febbraro - Current Oncology, 2022 - mdpi.com
Lung cancer is the leading cause of cancer death in Canada and a significant cause of
morbidity for patients and their loved ones. There have been rapid advances in preventing …
morbidity for patients and their loved ones. There have been rapid advances in preventing …
ESR/ERS statement paper on lung cancer screening
HU Kauczor, AM Baird, TG Blum, L Bonomo… - European …, 2020 - Springer
In Europe, lung cancer ranks third among the most common cancers, remaining the biggest
killer. Since the publication of the first European Society of Radiology and European …
killer. Since the publication of the first European Society of Radiology and European …
Impact of low‐dose computed tomography (LDCT) screening on lung cancer‐related mortality
A Bonney, R Malouf, C Marchal… - Cochrane Database …, 2022 - cochranelibrary.com
Background Lung cancer is the most common cause of cancer‐related death in the world,
however lung cancer screening has not been implemented in most countries at a population …
however lung cancer screening has not been implemented in most countries at a population …
Potential disparities by sex and race or ethnicity in lung cancer screening eligibility rates
PF Pinsky, YK Lau, CA Doubeni - Chest, 2021 - Elsevier
Background Criteria for low-dose CT scan lung cancer screening vary across guidelines.
Knowledge of the eligible pool across demographic groups can enable policy and …
Knowledge of the eligible pool across demographic groups can enable policy and …
[HTML][HTML] The cost-effectiveness of high-risk lung cancer screening and drivers of program efficiency
Introduction Lung cancer risk prediction models have the potential to make programs more
affordable; however, the economic evidence is limited. Methods Participants in the National …
affordable; however, the economic evidence is limited. Methods Participants in the National …
Low‐dose computed tomography lung cancer screening: Clinical evidence and implementation research
HL Lancaster, MA Heuvelmans… - Journal of Internal …, 2022 - Wiley Online Library
Lung cancer causes more deaths than breast, cervical, and colorectal cancer combined.
Nevertheless, population‐based lung cancer screening is still not considered standard …
Nevertheless, population‐based lung cancer screening is still not considered standard …
Lung cancer screening with low-dose CT in smokers: a systematic review and meta-analysis
T Hunger, E Wanka-Pail, G Brix, J Griebel - Diagnostics, 2021 - mdpi.com
Lung cancer continues to be one of the main causes of cancer death in Europe. Low-dose
computed tomography (LDCT) has shown high potential for screening of lung cancer in …
computed tomography (LDCT) has shown high potential for screening of lung cancer in …